ERIBULIN MESYLATE
Disclaimer: These predictions are for research purposes only. They do not constitute medical advice and require clinical validation.
Overview
| Property | Value |
|---|---|
| Drug Name | ERIBULIN MESYLATE |
| DrugBank ID | DB08871 |
| HSA Status | Registered with Health Sciences Authority |
| KG Predictions | 8 |
| DL Predictions (≥0.7) | 50 |
Predicted Indications
The following indications are predicted based on TxGNN knowledge graph analysis:
| Indication | Source | Evidence |
|---|---|---|
| chronic myelogenous leukemia, bcr-abl1 positive | TxGNN Knowledge Graph | L5 |
| precursor t-cell acute lymphoblastic leukemia | TxGNN Knowledge Graph | L5 |
| melanoma | TxGNN Knowledge Graph | L5 |
| leukemia, lymphocytic, susceptibility to | TxGNN Knowledge Graph | L5 |
| acute lymphoblastic/lymphocytic leukemia | TxGNN Knowledge Graph | L5 |
| lung neoplasm | TxGNN Knowledge Graph | L5 |
| acute lymphoblastic leukemia (disease) | TxGNN Knowledge Graph | L5 |
| lung cancer | TxGNN Knowledge Graph | L5 |
Evidence Summary
External Resources
Generated by SgTxGNN on 2026-03-11